免疫診断学の世界市場

免疫診断学の世界市場は2030年までに299億米ドルに達する見込み

2024年に246億米ドルと推定される免疫診断学の世界市場は、2024年から2030年にかけてCAGR 3.3%で成長し、2030年には299億米ドルに達すると予測されます。免疫診断学試薬は、本レポートで分析したセグメントの1つであり、CAGRは3.9％を記録し、分析期間終了時には168億米ドルに達すると予測されています。免疫診断学 Instrumentsセグメントの成長率は、分析期間中CAGR 2.7％と推定されます。

米国市場は67億米ドル、中国はCAGR6.3％で成長すると予測

米国の免疫診断学市場は、2024年に67億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR6.3％を引きずる形で、2030年までに60億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3％と2.6％と予測されています。欧州では、ドイツがCAGR 1.9%で成長すると予測されています。

世界の免疫診断学市場- 主要動向と促進要因のまとめ

免疫診断学が早期疾患検出とモニタリングに不可欠な理由とは？

免疫診断学は、抗原抗体相互作用を利用して、血液、尿、唾液などの患者サンプル中のバイオマーカーを検出・定量するラボベースの診断技術です。これらの検査は、感染症、自己免疫疾患、ホルモンバランスの乱れ、がん、アレルギーの診断に極めて重要です。これらの検査は、高い特異性、感度、迅速な納期により、病院、診断研究所、研究機関などで広く利用されています。ヘルスケアシステムが予防診断と早期介入に重点を置く中、免疫診断ツールは現代の医療検査における基礎となりつつあります。

その有用性は、酵素結合免疫吸着測定法（ELISA）や化学発光免疫測定法（CLIA）から、ポイント・オブ・ケア検査で使用されるラテラルフロー免疫測定法まで、定性と定量の両方のアプリケーションに及んでいます。分散型診断や在宅での健康モニタリングの需要が高まる中、免疫診断学はコンパクトなプラットフォームや多重化された検査フォーマットにも統合され、臨床および非臨床の両方でより利用しやすく効率的なものとなっています。

技術革新は検査の精度とスピードをどのように向上させていますか？

免疫診断学市場は、アッセイ化学、バイオセンサー設計、検出システムの進歩によって急速な変貌を遂げつつあります。ハイスループット自動分析装置、ナノ材料増強免疫測定法、デジタル免疫測定プラットフォームは、検査感度と多重化能力を大幅に向上させています。これらの技術革新により、1検体から複数のバイオマーカーを同時に検出できるようになり、がんスクリーニング、自己免疫プロファイリング、感染症パネルで特に有益です。

さらに、スマートフォン連動デバイスやマイクロ流体ラボオンチップ技術は、特に資源が限られた環境でのポイントオブケア用途を拡大しています。AI主導のアルゴリズムが診断ソフトウェアに統合され、解釈精度と臨床的意思決定が向上しています。さらに、蛍光、電気化学、光検出技術を取り入れることで、免疫診断ツールの分析性能が向上し、個別化医療や精密医療の信頼性が高まっています。

免疫診断検査の需要を牽引しているアプリケーションと地域は？

主な臨床アプリケーションには、感染症診断（HIV、肝炎、COVID-19など）、腫瘍マーカー（PSA、CA125など）、心血管リスクプロファイリング（トロポニンなど）、自己免疫パネル（ANA、リウマチ因子など）があります。病院と診断ラボが依然として最大のエンドユーザーであり、在宅医療、学術研究センター、バイオ製薬会社がこれに続きます。免疫診断検査に対する需要は、慢性疾患管理や手術後のモニタリングにおいて特に強いです。

北米は大手診断薬企業の存在、高いヘルスケア支出、強力な規制の枠組みにより優位を占めています。欧州は予防診断とスクリーニング・プログラムに重点が置かれつつあり、これに続きます。アジア太平洋は、中国やインドのような国々におけるヘルスケアへのアクセス向上、早期診断に対する意識の高まり、保険適用範囲の拡大などを背景に、最も急速に成長している地域です。アフリカやラテンアメリカでも、インフラや疾病監視プログラムの改善に伴い、導入が拡大しています。

免疫診断学市場の成長はいくつかの要因によって牽引...

免疫診断学市場の成長は、慢性疾患や感染症の世界の増加、アッセイの自動化と感度の進歩、迅速で正確な診断に対する需要の増加など、いくつかの要因によってもたらされます。マルチプレックスイムノアッセイ、ラボオンチップシステム、AIを活用した検査プラットフォームなどの技術改良により、臨床およびポイントオブケアでの利用が拡大しています。新しいバイオマーカーや検査キットに対する規制当局の承認も市場拡大に寄与しています。

最終用途の観点からは、在宅検査の普及、個別化医療への投資の拡大、医薬品開発ワークフローへの免疫診断学の統合が需要を促進しています。特に腫瘍学や感染症における政府のスクリーニングプログラム、分散型ラボネットワークの拡大も主要な成長要因です。現代ヘルスケアにおいて診断精度がますます重要になる中、免疫診断学は世界の検査室医療の要であり続けるでしょう。

セグメント

製品タイプ（試薬、機器、ソフトウェア＆サービス）、技術（酵素結合免疫吸着測定法、化学発光免疫測定法、蛍光免疫測定法、放射免疫測定法、その他の技術）、用途（感染症、腫瘍・内分泌、骨・ミネラル疾患、自己免疫疾患、心臓バイオマーカー、薬物モニタリング、その他の用途）、最終用途（病院、臨床検査室、学術・研究機関、その他の最終用途）

調査対象企業の例（注目の34社）

• Abbott Laboratories
• Agilent Technologies, Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid
• DiaSorin S.p.A.
• Erba Diagnostics Mannheim GmbH
• F. Hoffmann-La Roche AG
• Grifols, S.A.
• Guardant Health
• Illumina, Inc.
• Immunodiagnostic Systems Holdings PLC
• Inova Diagnostics, Inc.
• Johnson & Johnson
• NeoGenomics Laboratories
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Immunodiagnostics Market to Reach US$29.9 Billion by 2030

The global market for Immunodiagnostics estimated at US$24.6 Billion in the year 2024, is expected to reach US$29.9 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Immunodiagnostics Reagents, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$16.8 Billion by the end of the analysis period. Growth in the Immunodiagnostics Instruments segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.7 Billion While China is Forecast to Grow at 6.3% CAGR

The Immunodiagnostics market in the U.S. is estimated at US$6.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Immunodiagnostics Market - Key Trends & Drivers Summarized

Why Are Immunodiagnostics Critical in Early Disease Detection and Monitoring?

Immunodiagnostics are laboratory-based diagnostic techniques that utilize antigen-antibody interactions to detect and quantify biomarkers in patient samples such as blood, urine, or saliva. These tests are crucial in diagnosing infectious diseases, autoimmune disorders, hormonal imbalances, cancer, and allergies. They are widely used in hospitals, diagnostic laboratories, and research institutions for their high specificity, sensitivity, and rapid turnaround time. As healthcare systems focus on preventive diagnostics and early intervention, immunodiagnostic tools are becoming foundational in modern medical testing.

Their utility spans both qualitative and quantitative applications, ranging from enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays (CLIA) to lateral flow immunoassays used in point-of-care testing. With increasing demand for decentralized diagnostics and home-based health monitoring, immunodiagnostics are also being integrated into compact platforms and multiplexed test formats, making them more accessible and efficient in both clinical and non-clinical settings.

How Are Technological Innovations Enhancing Test Accuracy and Speed?

The immunodiagnostics market is undergoing rapid transformation through advancements in assay chemistry, biosensor design, and detection systems. High-throughput automated analyzers, nanomaterial-enhanced immunoassays, and digital immunoassay platforms are significantly improving test sensitivity and multiplexing capabilities. These innovations are allowing for the simultaneous detection of multiple biomarkers from a single sample, which is particularly beneficial in cancer screening, autoimmune profiling, and infectious disease panels.

Additionally, smartphone-linked devices and microfluidic lab-on-chip technologies are expanding point-of-care applications, especially in resource-limited settings. AI-driven algorithms are being integrated into diagnostic software to improve interpretation accuracy and clinical decision-making. Moreover, the incorporation of fluorescence, electrochemical, and photonic detection techniques is enhancing the analytical performance of immunodiagnostic tools, making them more reliable for personalized and precision medicine.

Which Applications and Regions Are Driving Demand for Immunodiagnostic Testing?

Key clinical applications include infectious disease diagnostics (e.g., HIV, hepatitis, COVID-19), oncology markers (e.g., PSA, CA125), cardiovascular risk profiling (e.g., troponins), and autoimmune panels (e.g., ANA, rheumatoid factor). Hospitals and diagnostic labs remain the largest end-users, followed by home healthcare, academic research centers, and biopharmaceutical companies. The demand for immunodiagnostic testing is especially strong in chronic disease management and post-surgical monitoring.

North America dominates due to the presence of leading diagnostic firms, high healthcare spending, and a strong regulatory framework. Europe follows with growing emphasis on preventive diagnostics and screening programs. Asia-Pacific is the fastest-growing region, driven by rising healthcare access in countries like China and India, increasing awareness of early diagnosis, and expanding insurance coverage. Africa and Latin America are also seeing growing adoption as infrastructure and disease surveillance programs improve.

The Growth in the Immunodiagnostics Market Is Driven by Several Factors…

The growth in the immunodiagnostics market is driven by several factors including the global rise in chronic and infectious diseases, advances in assay automation and sensitivity, and increasing demand for rapid and accurate diagnostics. Technological improvements in multiplex immunoassays, lab-on-chip systems, and AI-enhanced test platforms are expanding both clinical and point-of-care use. Regulatory approvals for new biomarkers and test kits are also contributing to market expansion.

From an end-use perspective, the rising adoption of home-based testing, growing investment in personalized medicine, and the integration of immunodiagnostics in drug development workflows are fueling demand. Government screening programs, especially in oncology and infectious diseases, and the expansion of decentralized lab networks are also key growth contributors. As diagnostic precision becomes increasingly vital in modern healthcare, immunodiagnostics will continue to be a cornerstone of laboratory medicine worldwide.

SCOPE OF STUDY:

The report analyzes the Immunodiagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reagents, Instruments, Software & Services); Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Other Technologies); Application (Infectious Diseases, Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications); End-Use (Hospitals, Clinical Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid
• DiaSorin S.p.A.
• Erba Diagnostics Mannheim GmbH
• F. Hoffmann-La Roche AG
• Grifols, S.A.
• Guardant Health
• Illumina, Inc.
• Immunodiagnostic Systems Holdings PLC
• Inova Diagnostics, Inc.
• Johnson & Johnson
• NeoGenomics Laboratories
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Immunodiagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Prevalence of Infectious and Chronic Diseases Drives Demand for Immunodiagnostic Testing
  • Increased Use of Immunoassays in Oncology and Autoimmune Disease Detection Expands Market Scope
  • Technological Advancements in Chemiluminescence and ELISA Platforms Enhance Sensitivity and Speed
  • Point-of-Care Immunodiagnostics Gain Momentum With Growth in Decentralized Testing Models
  • Integration of AI and Machine Learning Improves Accuracy and Interpretation of Immunoassay Results
  • Growing Demand for Early Disease Screening Programs Spurs Adoption in Preventive Diagnostics
  • Expansion of Home Testing Kits and Wearable Immuno-Biomarkers Drives Direct-to-Consumer Growth
  • Emergence of Multiplexed Immunodiagnostic Platforms Enables Simultaneous Disease Detection
  • Rise in Companion Diagnostics Supports Personalized Therapy Selection in Immuno-Oncology
  • Miniaturization and Lab-on-Chip Technologies Expand Applications in Resource-Limited Settings
  • Hospital Automation and LIS Integration Enhance Workflow Efficiency for High-Throughput Testing
  • Increasing Geriatric Population With Comorbidities Accelerates Demand for Broad-Spectrum Diagnostic Panels
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Immunodiagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Oncology & Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Oncology & Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Oncology & Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bone & Mineral Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bone & Mineral Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Bone & Mineral Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Drug Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Enzyme-linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Enzyme-linked Immunosorbent Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Chemiluminescence Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Chemiluminescence Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Fluorescent Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Fluorescent Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Fluorescent Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Radioimmunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• JAPAN
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• CHINA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• EUROPE
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Immunodiagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• FRANCE
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 125: France Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• GERMANY
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 161: UK Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: UK 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Spain 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Spain 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Russia 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Russia 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Russia 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Immunodiagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Australia 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Australia 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Australia 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• INDIA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 236: India Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: India 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: India 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: India 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: South Korea 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: South Korea 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: South Korea 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Immunodiagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Latin America 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Latin America 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Argentina 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Argentina 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Argentina 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Brazil 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Brazil 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Brazil 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Mexico 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Mexico 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Mexico 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Immunodiagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Middle East 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Middle East 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Iran 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Iran 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Iran 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Israel 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Israel 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Israel 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: UAE 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: UAE 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: UAE 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• AFRICA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Africa 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Africa 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Africa 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION